NL-OMON29764已完成2 期
Phase II single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors - ITCC-GemOx study
Institue Goustave Roussy0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •- relapsed or refractory pediatric solid tumors
- •- age 6 months up to 21 years
- •- measurable primary and/or metastatic disease
- •- no more than 1 salvage therapy for relapse
- •- Lansky play score over 60 or ECOG 1
- •- adequate organ function
- •- life expectancy > 3 months
- •- wash out or prior therapy of 3 weeks
- •- written informed consent
排除标准
- •- Other antitumor therapy
- •- pre-existing sensory or motor neuropathy >grade 2 (except when caused by tumor)
- •- allergic reaction to platinum compounds
- •- symptomatic brain metastases
研究者
相似试验
进行中（未招募）
1 期
Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors. - ITCC-004-GEMOXRefractory or relapsing malignant pediatric solid tumors.EUCTR2006-001065-41-GBniversity Hospitals of Leicester NHS Trust, Research and Development Directorate156
进行中（未招募）
不适用
Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors - ITCC-004-GEMOXrefractory or relapsing malignant pediatric solid tumorsEUCTR2006-001065-41-DEInstitut Gustave Roussy156
进行中（未招募）
不适用
Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors.(Etude de phase II de l’association Gemcitabine - Oxaliplatine « GEMOX » chez les patients porteurs d’une tumeur solide maligne réfractaire ou en rechute). - ITCC-004-GEMOXrefractory or relapsing malignant pediatric solid tumors.EUCTR2006-001065-41-NLInstitut Gustave Roussy156
进行中（未招募）
不适用
Phase 2 single-arm studies of Gemcitabine in combination with Oxaliplatin in refractory and relapsed pediatric solid tumors - ITCC-004-GEMOXEUCTR2006-001065-41-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI156
进行中（未招募）
不适用
A Phase 2 Single-Arm study of gemcitabine in combination with Oxaliplatin in Pediatric patients with relapsed or refractory neuroblastoma or miscellaneous solid non-CNS tumors - NDEUCTR2005-005219-36-ITELI LILLY49